In vitro simulation of food effect on dissolution of deramciclane film-coated tablets and correlation with in vivo data in healthy volunteers

被引:17
|
作者
Al-Behaisi, S
Antal, I
Morovján, G
Szúnyog, J
Drabant, S
Marton, S
Klebovich, I
机构
[1] EGIS Pharmaceut Ltd, Res & Dev Directorate, H-1106 Budapest, Hungary
[2] Semmelweis Univ, Inst Pharmaceut, H-1092 Budapest, Hungary
关键词
deramciclane; dissolution; food effect; AUC(cum); in vitro-in vivo correlation;
D O I
10.1016/S0928-0987(01)00195-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The in vitro dissolution profiles of deramciclane 30 mg film-coated tablets, an acid-labile new 5-HT receptor antagonist, were studied under simulated fasting and fed conditions. Artificial gastric juice with pH adjusted to that of fasting conditions was applied either alone or after adding different dietary components. The use of the USP dissolution apparatus 11 (paddle method) showed that the presence of dietary components has markedly affected the amount of unchanged drug dissolved. As a similar tendency bad been observed in food-effect studies in healthy volunteers, cumulative area under the curve (AUC(cum)) for both fed and fasting conditions were compared and an in vitro-in vivo correlation (IVIVC) was evaluated. A linear relationship was established between logarithmic in vivo blood sampling tune and in vitro dissolution time assigned to equal AUC(cum) ratios (AUC(cum), (fed)/AUC(cum), (fasting)). Despite its limitations. in vitro modelling of in vivo conditions might help provide a base for predicting in vivo drug behaviour. (C) 2002 Published by Elsevier Science B.V.
引用
下载
收藏
页码:157 / 162
页数:6
相关论文
共 36 条
  • [31] Multiple level C in vitro/in vivo correlation of dissolution profiles of two L-thyroxine tablets with pharmacokinetics data obtained from patients treated for hypothyroidism
    Volpato, NM
    Silva, RL
    Brito, APP
    Gonçalves, JCS
    Vaisman, M
    Noël, F
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 21 (05) : 655 - 660
  • [32] Pharmacokinetic dose proportionality between two strengths (12.5 mg and 25 mg) of doxylamine hydrogen succinate film-coated tablets in fasting state: A single-dose, randomized, two-period crossover study in healthy volunteers
    Videla S.
    Cebrecos J.
    Lahjou M.
    Wagner F.
    Guibord P.
    Xu Z.
    Cabot A.
    Encabo M.
    Encina G.
    Sicard E.
    Sans A.
    Drugs in R&D, 2013, 13 (2) : 129 - 135
  • [33] Bioequivalence Study of Two Formulations of Ibandronic Acid 150-mg Film-Coated Tablets in Healthy Volunteers Under Fasting Conditions: A Randomized, Open-Label, Three-Way, Reference-Replicated Crossover Study
    Filipe, Augusto
    Pedroso, Pedro
    Almeida, Susana
    Neves, Rita
    Boudreault, Sylvie
    DRUGS IN R&D, 2014, 14 (02) : 105 - 112
  • [34] Single- and Multiple-Dose Pharmacokinetics of a Novel Tetramethylpyrazine Reservoir-Type Transdermal Patch versus Tetramethylpyrazine Phosphate Oral Tablets in Healthy Normal Volunteers, and in Vitro/in Vivo Correlation
    Shen, Teng
    Xu, Huinan
    Weng, Weiyu
    Zhang, Jianfang
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2013, 36 (06) : 931 - 937
  • [35] Bioequivalence of Two Film-Coated Tablets of Imatinib Mesylate 400 mg: A Randomized, Open-Label, Single-Dose, Fasting, Two-Period, Two-Sequence Crossover Comparison in Healthy Male South American Volunteers
    Parrillo-Campiglia, Susana
    Cedres Ercoli, Monica
    Umpierrez, Ofelia
    Rodriguez, Patricia
    Marquez, Sara
    Guarneri, Carolina
    Estevez-Parrillo, Francisco T.
    Laurenz, Marilena
    Estevez-Carrizo, Francisco E.
    CLINICAL THERAPEUTICS, 2009, 31 (10) : 2224 - 2232